v3.26.1
Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flows from operating activities    
Net Income (Loss) $ (2,874,601) $ (1,418,981)
Reconciliation of net loss to net cash used in operating activities    
Depreciation and amortization 145,852 118,798
Stock based compensation 1,020,478 1,674,710
Extinguishment of debt (2,417,502)
Issuance of warrants for interest expense 24,477 12,450
Loss on Disposal of assets 1,360
Changes in operating assets and liabilities    
Prepaid expenses 20,938 3,261
Accounts payable (66,092) 200,629
Accounts payable - related party (24,100)
Deferred wages and directors fees - related party 917,265 779,558
Interest payable - related party (9,219) 42,297
Net cash used in operating activities (845,002) (1,003,420)
Cash flows from investing activities    
Purchase of property and equipment (68,898) (71,138)
Payment of deposits on property (50,000)
Additions to patent and trademark costs (18,447) (44,653)
Net cash from (used in) investing activities (137,345) (115,791)
Cash flows from financing activities    
Proceeds from issuance of common stock 745,000 197,000
Proceeds from the issuance of convertible notes - RP 185,000 680,000
Proceeds from the issuance of convertible notes - Other 250,000
Proceeds from exercise of warrants 68,750
Net cash provided by financing activities 998,750 1,127,000
Net increase (decrease) in cash and cash equivalents 16,403 7,789
Cash and cash equivalent at beginning of the year 48,797 41,008
Cash and cash equivalent at end of the year 65,200 48,797
Supplemental schedule of non-cash financing and investing activities    
Recognition of operating lease liability and right-of-use asset 452,132
Issuance of common stock for patent and trademark costs 38,463
Issuance of common stock for property and equipment 67,253
Issuance of common stock and warrants on the conversion of notes payable $ 50,000 $ 250,000